Quantapore Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Quantapore General Information
Description
Developer of a protein fingerprinting technology designed to analyze biological molecules such as protein or deoxyribonucleic acid(DNA). The company's technology is based on an optically labeled nanopore that interacts via energy transfer with a labeled nucleic acid sample to allow rapid, affordable, and sensitive sequencing of entire genomes, enabling medical professionals to improve human health and the world.
Contact Information
Website
www.quantapore.comCorporate Office
- 815 Dubuque Avenue
- South San Francisco, CA 94080
- United States
Corporate Office
- 815 Dubuque Avenue
- South San Francisco, CA 94080
- United States
Quantapore Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | Completed | Product Development | ||||
| 8. Later Stage VC | 22-Oct-2021 | Completed | Product Development | |||
| 7. Debt - PPP | 14-Apr-2020 | Completed | Startup | |||
| 6. Later Stage VC (Series 3) | 18-Jul-2018 | Completed | Startup | |||
| 5. Later Stage VC (Series 1) | 15-Jun-2017 | Completed | Startup | |||
| 4. Later Stage VC (Series 1) | 02-Feb-2017 | Completed | Startup | |||
| 3. Later Stage VC (Series C) | 27-Sep-2016 | Completed | Startup | |||
| 2. Later Stage VC (Series B) | 21-May-2014 | $6.8M | $8M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 11-Apr-2011 | $1.2M | $1.2M | Completed | Startup |
Quantapore Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 4 | ||||||||
| Series 3 | ||||||||
| Series 2C | ||||||||
| Series 2B | ||||||||
| Series 2A | 13,621 | $0.000010 | $8.47 | $8.47 | 1x | $8.47 | 0.02% | |
| Series 1 | 29,899,500 | $0.000010 | $0.01 | $0.1 | $0.1 | 1x | $0.1 | 34.88% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Quantapore Comparisons
Industry
Financing
Details
Quantapore Competitors (39)
One of Quantapore’s 39 competitors is Autogenomics, a Formerly VC-backed company based in Carlsbad, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Autogenomics | Formerly VC-backed | Carlsbad, CA | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| OncoDNA | Venture Capital-Backed | Gosselies, Belgium | ||||
| Parse Biosciences | Formerly VC-backed | Seattle, WA | ||||
| Vizgen | Venture Capital-Backed | Cambridge, MA |
Quantapore Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Quantapore Patents
Quantapore Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024059754-A1 | Polythiolated linkers for stable nanoparticle suspensions and uses thereof | Inactive | 14-Sep-2022 | ||
| WO-2023023561-A1 | Multiplex binding assays with optical nanopore readout | Inactive | 17-Aug-2021 | ||
| WO-2022261607-A1 | Polypeptide sequencing and fingerprinting | Inactive | 09-Jun-2021 | ||
| AU-2021259879-A1 | Fluorescent polynucleotide sequencing methods and compositions | Inactive | 24-Apr-2020 | ||
| CA-3179981-A1 | Fluorescent polynucleotide sequencing methods and compositions | Pending | 24-Apr-2020 | C12Y301/11 |
Quantapore Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Quantapore Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Baidu Ventures | Corporate Venture Capital | Minority | ||
| Cloudstone Capital | Venture Capital | Minority | ||
| Foothill Ventures | Venture Capital | Minority | ||
| Fusion Fund | Venture Capital | Minority | ||
| Northern Light Venture Capital | Venture Capital | Minority |
Quantapore FAQs
-
When was Quantapore founded?
Quantapore was founded in 2009.
-
Where is Quantapore headquartered?
Quantapore is headquartered in South San Francisco, CA.
-
What is the size of Quantapore?
Quantapore has 17 total employees.
-
What industry is Quantapore in?
Quantapore’s primary industry is Other Healthcare Technology Systems.
-
Is Quantapore a private or public company?
Quantapore is a Private company.
-
What is Quantapore’s current revenue?
The current revenue for Quantapore is .
-
How much funding has Quantapore raised over time?
Quantapore has raised $41.3M.
-
Who are Quantapore’s investors?
Baidu Ventures, Cloudstone Capital, Foothill Ventures, Fusion Fund, and Northern Light Venture Capital are 5 of 7 investors who have invested in Quantapore.
-
Who are Quantapore’s competitors?
Autogenomics, Oxford Nanopore Technologies, OncoDNA, Parse Biosciences, and Vizgen are some of the 39 competitors of Quantapore.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
